Stevens David R's Form 4 filing
Ampio Pharmaceuticals, Inc. (AMPE) · filed May 12, 2023
- Accession no.
- 0001615594-23-000031
- Filed
- May 12, 2023, 5:26 PM ET
- Trade date
- May 11-12, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $20.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stevens David RCIK 0001292382 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2023 | Common Stock | PPurchaseAcquired | +25,000 | $0.22 | +$5,500 | 33,971 | Direct | |
| May 11, 2023 | Common Stock | PPurchaseAcquired | +25,000 | $0.215 | +$5,375 | 58,971 | Direct | |
| May 12, 2023 | Common Stock | PPurchaseAcquired | +45,000 | $0.22 | +$9,900 | 103,971 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.